Teva Pharmaceutical Industries (TEVA) Short Interest Ratio & Short Volume

Teva Pharmaceutical Industries logo
$38.53 -3.70 (-8.76%)
Closing price 11/19/2026
Extended Trading
$38.97 +0.44 (+1.14%)
As of 07:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teva Pharmaceutical Industries Short Interest Overview

As of October 30, 2026, Teva Pharmaceutical Industries (TEVA) had a short interest of 27.74 million shares sold short, representing 2.39% of the public float. This marks a 1.18% decrease in short interest since the prior report. The short interest ratio (days to cover) is 5.3, meaning it would take 5.3 days of the average trading volume of 7.58 million shares to cover all short positions.

Current Short Interest
27,739,194 shares
Previous Short Interest
28,070,513 shares
Change Vs. Previous Report
-1.18%
Dollar Volume Sold Short
$1.17 billion
Short Interest Ratio
5.3 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
1,165,296,000 shares
Short Percent of Float
2.39%
Today's Trading Volume
10,369,385 shares
Average Trading Volume
7,582,873 shares
Today's Volume Vs. Average
137%
Short Selling Teva Pharmaceutical Industries?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

TEVA Short Interest Over Time

TEVA Days to Cover Over Time

TEVA Percentage of Float Shorted Over Time

Teva Pharmaceutical Industries Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/202627,739,194 shares $1.17 billion -1.2%2.4%5.3 $42.07
10/15/202628,070,513 shares $1.16 billion -6.0%2.4%3.92 $41.16
9/30/202629,848,805 shares $1.18 billion -5.2%2.6%5.4 $39.64
9/15/202631,478,314 shares $1.23 billion +11,467.5%2.7%27.35 $39.16
8/31/202637,614,253 shares $1.36 billion +5.5%3.2%7.71 $36.03
8/14/202635,670,864 shares $1.31 billion +3.9%3.1%6.63 $36.79
7/31/202634,320,980 shares $1.20 billion +4.8%3.0%5.74 $35.05
7/15/202632,741,011 shares $1.03 billion +2.2%2.9%6.51 $31.58
6/30/202632,029,657 shares $1.09 billion -4.0%2.8%5.1 $33.94
6/15/202633,346,891 shares $1.12 billion -1.5%2.9%5.42 $33.66
5/29/202633,869,008 shares $1.20 billion +27.1%3.0%6 $35.32
5/15/202626,651,458 shares $913.80 million -14.4%2.3%3.99 $34.29
4/30/202631,140,457 shares $1.09 billion +4.7%2.7%4 $35.03
4/15/202629,736,398 shares $940.06 million +10.0%2.6%7.1 $31.61
3/31/202627,042,748 shares $814.45 million -28.1%2.4%3.83 $30.12
3/13/202637,623,025 shares $1.07 billion +15.7%3.3%4.24 $28.54
2/27/202632,527,649 shares $1.10 billion -11.2%2.8%5.04 $33.85
2/13/202636,644,722 shares $1.24 billion -3.5%3.2%3.63 $33.96
1/30/202637,953,087 shares $1.29 billion +15.1%3.3%3.48 $34.08
1/15/202632,969,413 shares $1.07 billion +0.3%2.9%2.9 $32.36
12/31/202532,862,069 shares $1.03 billion -26.9%2.9%4.72 $31.21
12/15/202544,936,239 shares $1.35 billion -1.5%3.9%4.12 $30.10
11/28/202545,620,941 shares $1.23 billion -1.8%4.0%4.31 $26.94
11/14/202546,443,487 shares $1.18 billion -7.8%4.1%2.52 $25.40
10/31/202550,392,932 shares $1.03 billion +6.6%4.4%5.82 $20.50
10/15/202547,280,000 shares $936.00 million -5.2%4.1%4.4 $19.80
9/30/202549,880,000 shares $1.01 billion -9.6%N/A4.5 $20.15
9/15/202555,190,000 shares $1.04 billion +9.3%N/A5 $18.90
8/31/202550,510,000 shares $929.69 million +9.2%4.4%4.5 $18.41
8/15/202546,260,000 shares $826.20 million -7.3%N/A4 $17.86
7/31/202549,890,000 shares $771.10 million -6.6%4.4%4.3 $15.46
7/15/202553,420,000 shares $857.07 million +34.0%N/A4.6 $16.04
6/30/202539,870,000 shares $668.22 million -0.3%3.5%3.3 $16.76
6/15/202540,000,000 shares $679.88 million +12.1%3.5%3.3 $17.00
5/31/202535,670,000 shares $598.19 million -7.8%3.2%2.9 $16.77
5/15/202538,700,000 shares $651.32 million +36.1%3.4%3.1 $16.83
4/30/202528,430,000 shares $440.95 million -6.3%N/A2.3 $15.51
4/15/202530,340,000 shares $412.17 million -6.3%2.7%2.4 $13.59
3/31/202532,390,000 shares $498.32 million -6.9%2.9%2.5 $15.39
3/15/202534,800,000 shares $569.85 million +25.1%3.1%2.8 $16.38
My $247 scanner for $7 (Ad)

Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
2/28/202527,810,000 shares $457.47 million +4.3%2.5%2.2 $16.45
2/15/202526,660,000 shares $432.83 million +19.2%2.4%2.2 $16.24
1/31/202522,360,000 shares $398.12 million +41.5%N/A2 $17.81
1/15/202515,800,000 shares $346.02 million -41.8%N/A1.7 $21.90
12/31/202427,130,000 shares $597.95 million +16.8%N/A3.2 $22.04
12/15/202423,220,000 shares $383.13 million +3.6%N/A2.9 $16.50
11/30/202422,410,000 shares $376.04 million +5.8%N/A3.3 $16.78
11/15/202421,190,000 shares $348.26 million +17.1%N/A3.1 $16.44
10/31/202418,090,000 shares $333.76 million -9.1%N/A2.7 $18.45
10/15/202419,910,000 shares $361.57 million -18.7%N/A2.7 $18.16
9/30/202424,490,000 shares $441.31 million -19.3%N/A3 $18.02
9/15/202430,340,000 shares $558.56 million +26.7%N/A3.5 $18.41
8/31/202423,950,000 shares $451.94 million -0.2%N/A2.7 $18.87
8/15/202423,990,000 shares $439.62 million +23.0%N/A2.7 $18.33
7/31/202419,500,000 shares $339.69 million +10.3%N/A1.9 $17.42
7/15/202417,680,000 shares $301.97 million -20.8%N/A1.8 $17.08
6/30/202422,310,000 shares $362.54 million -9.2%N/A2.2 $16.25
6/15/202424,560,000 shares $421.45 million +35.8%N/A2.5 $17.16
5/31/202418,080,000 shares $306.09 million +39.1%N/A1.9 $16.93
5/15/202413,000,000 shares $218.14 million +6.4%N/A1.3 $16.78
4/30/202412,220,000 shares $171.45 million +4.8%N/A1.3 $14.03
4/15/202411,660,000 shares $154.26 million +0.9%N/A1.1 $13.23
3/31/202411,560,000 shares $163.11 million +10.5%N/A1.1 $14.11
3/15/202410,460,000 shares $140.53 million -28.9%N/A1 $13.44
2/29/202414,720,000 shares $193.27 million -4.4%N/A1.4 $13.13
2/15/202415,390,000 shares $202.99 million -16.0%N/A1.5 $13.19
1/31/202418,320,000 shares $221.67 million +9.3%N/A1.8 $12.10
1/15/202416,760,000 shares $189.72 million +2.5%N/A1.9 $11.32
12/31/202316,350,000 shares $170.69 million +15.8%N/A1.9 $10.44
12/15/202314,120,000 shares $140.92 million +6.1%N/A1.7 $9.98
11/30/202313,310,000 shares $130.77 million -6.1%N/A1.5 $9.83
11/15/202314,180,000 shares $127.19 million -18.9%N/A1.7 $8.97
10/31/202317,490,000 shares $150.06 million +19.2%N/A2.1 $8.58
10/15/202314,670,000 shares $127.04 million +8.1%N/A1.6 $8.66
9/30/202313,570,000 shares $138.41 million -19.5%N/A1.4 $10.20
9/15/202316,850,000 shares $178.10 million -0.3%N/A1.8 $10.57
8/31/202316,900,000 shares $164.94 million -18.4%N/A1.7 $9.76
8/15/202320,710,000 shares $197.47 million -8.8%N/A1.7 $9.54
7/31/202322,710,000 shares $190.65 million +18.7%N/A1.6 $8.40
7/15/202319,130,000 shares $157.06 million +18.7%N/A1.5 $8.21
6/30/202316,120,000 shares $121.30 million -24.4%N/A1.2 $7.53
6/15/202321,330,000 shares $161.68 million +0.1%N/A1.6 $7.58
5/31/202321,300,000 shares $153.15 million +52.5%N/A1.6 $7.19
5/15/202313,970,000 shares $112.74 million +9.7%N/A1.2 $8.07
4/30/202312,730,000 shares $111.13 million -16.6%N/A1.4 $8.73
4/15/202315,260,000 shares $126.51 million -7.4%N/A1.7 $8.29
3/31/202316,480,000 shares $145.85 million -15.9%N/A1.8 $8.85
3/15/202319,590,000 shares $169.85 million -23.4%N/A2.2 $8.67
2/28/202325,570,000 shares $253.40 million -7.6%N/A2.9 $9.91
2/15/202327,680,000 shares $285.38 million -2.4%N/A3.1 $10.31
My $247 scanner for $7 (Ad)

Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
1/31/202328,350,000 shares $298.81 million +13.3%N/A2.9 $10.54
1/15/202325,020,000 shares $281.22 million -20.5%N/A2.6 $11.24
12/30/202231,470,000 shares $287.01 million +31.2%N/A3.3 $9.12
12/15/202223,980,000 shares $214.86 million -22.7%N/A2.6 $8.96
11/30/202231,030,000 shares $272.13 million +0.7%N/A3.4 $8.77
11/15/202230,810,000 shares $282.84 million +2.1%N/A3.3 $9.18
10/31/202230,190,000 shares $269.29 million +3.8%N/A2.9 $8.92
10/15/202229,080,000 shares $231.19 million -0.2%N/A2.3 $7.95
9/30/202229,150,000 shares $235.24 million +12.4%N/A2.2 $8.07
9/15/202225,940,000 shares $230.61 million +28.0%N/A1.9 $8.89
8/31/202220,270,000 shares $183.24 million -9.8%N/A1.4 $9.04
8/15/202222,460,000 shares $251.55 million +11.8%N/A1.6 $11.20
7/31/202220,090,000 shares $188.44 million +13.1%N/A1.5 $9.38
7/15/202217,760,000 shares $124.50 million +4.1%N/A1.7 $7.01
6/30/202217,060,000 shares $128.29 million -12.0%N/A1.7 $7.52
6/15/202219,380,000 shares $157.56 million +1.8%1.8%1.9 $8.13
5/31/202219,040,000 shares $173.26 million -7.0%N/A2.2 $9.10
5/15/202220,470,000 shares $158.85 million +21.2%N/A2.3 $7.76
4/30/202216,890,000 shares $147.11 million -7.5%N/A1.9 $8.71
4/15/202218,260,000 shares $186.07 million -12.7%N/A2.1 $10.19
3/31/202220,910,000 shares $196.34 million -3.7%N/A2.3 $9.39
3/15/202221,720,000 shares $162.90 million +5.4%N/A2.4 $7.50
2/28/202220,610,000 shares $167.56 million +12.3%N/A2.2 $8.13
2/15/202218,360,000 shares $155.33 million -16.6%N/A1.9 $8.46
1/31/202222,020,000 shares $185.63 million +4.3%N/A2.3 $8.43
1/15/202221,110,000 shares $193.58 million +14.1%N/A2 $9.17
12/31/202118,500,000 shares $148.19 million -7.7%N/A1.9 $8.01
12/15/202120,040,000 shares $163.73 million +3.7%N/A2.1 $8.17
11/30/202119,330,000 shares $159.47 million -1.3%N/A2 $8.25

TEVA Short Interest - Frequently Asked Questions

Short interest is the volume of Teva Pharmaceutical Industries shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 27,739,194 shares of TEVA short. 2.39% of Teva Pharmaceutical Industries' shares are currently sold short. Learn More on Teva Pharmaceutical Industries' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TEVA shares currently have a short interest ratio of 5.3. Learn More on Teva Pharmaceutical Industries's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.39% of Teva Pharmaceutical Industries' floating shares are currently sold short.

Teva Pharmaceutical Industries saw a decrease in short interest since the prior report. As of October 30th, there was short interest totaling 27,739,194 shares, a decrease of 1.2% from the previous total of 28,070,513 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.39% of Teva Pharmaceutical Industries' shares are currently sold short. Here is how the short interest of companies in the sector of "healthcare" compare to Teva Pharmaceutical Industries: AbbVie Inc. (0.90%), Novo Nordisk A/S (0.86%), Pfizer Inc. (2.37%), Bristol Myers Squibb Company (2.29%), Sanofi (0.51%), GSK PLC Sponsored ADR (0.89%), Takeda Pharmaceutical Co. (0.10%), BeOne Medicines Ltd. - Sponsored ADR (1.56%), Royalty Pharma PLC (2.80%), Zoetis Inc. (4.06%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling TEVA is an investing strategy that aims to generate trading profit from Teva Pharmaceutical Industries as its price is falling. TEVA shares are trading down $3.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Teva Pharmaceutical Industries occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TEVA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TEVA, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TEVA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NYSE:TEVA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners